Cargando…
A novel synthetic microtubule inhibitor exerts antiproliferative effects in multidrug resistant cancer cells and cancer stem cells
The success of cancer chemotherapy is limited by multidrug resistance (MDR), which is mainly caused by P-glycoprotein (P-gp) overexpression. In the present study, we describe a novel microtubule inhibitor, 5-(N-methylmaleimid-3-yl)-chromone (SPC-160002), that can be used to overcome MDR. A synthetic...
Autores principales: | Park, Mina, Hwang, Jee Won, Cho, Yena, Kim, Saegun, Han, Sang Hoon, Yu, Jinsuh, Ha, Sojung, Kim, Woo-Young, Kim, Su-Nam, Kim, In Su, Kim, Yong Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144389/ https://www.ncbi.nlm.nih.gov/pubmed/34031528 http://dx.doi.org/10.1038/s41598-021-90337-w |
Ejemplares similares
-
Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
por: Cho, Yena, et al.
Publicado: (2020) -
Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021) -
Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells
por: Hire, Rupali R., et al.
Publicado: (2017) -
Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
por: Kim, Hyeon Ji, et al.
Publicado: (2021) -
Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1
por: Kim, Hak-Bong, et al.
Publicado: (2015)